NCT05431348Completed
Effect of stRess and exeRcize on the Outcome After Chemo-Radiation
Source: ClinicalTrials.gov · Last updated 4 Mar 2026
Brief summary (registry, in English)
Glioblastoma (GBM) is a highly malignant, incurable primary brain tumor. Due to the nature of this disease and the extent of the treatment (surgery followed by chemoradiation according to the Stupp trial) patients undergo considerable psychological distress. It is known that stress hormones are involved in a wide range of processes involved in cell survival, cell cycle and immune function, and can cause therapy resistance. In this study the effect of stress on outcome after chemoradiation in patients with GBM will be investigated.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 42 (actual)
- First submitted
- 22 Feb 2022
- Start date
- 1 Jun 2022
- Primary completion date
- 1 Mar 2026
- Lead sponsor
- Maastricht Radiation Oncology
- Diseases
- Glioblastoma
- NCT number
- NCT05431348
What you commit to
- Study type: Observational
- Participants enrolled: 42
- From 1 Jun 2022 to the primary completion date, 1 Mar 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- younger than 18 years
Other
- not in possession of a smart phone
Who the study is looking for
- Patients treated with Stupp or Elderly protocol: GBM WHO IV, astrocytoma WHO IV IDHmt, astrocytoma WHO II IDHwt (GBM-like).
- willing to wear the smart watch during the treatment protocol
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Maastricht Radiation Oncology (Maastro) Coordinator of this site? Confirm its status | Maastricht | Netherlands | Unknown status |
| Verbeeten Insitute Tilburg Coordinator of this site? Confirm its status | Tilburg | Netherlands | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.